- 1. DOX-MTC
- [A formulation of doxorubicin bound to microscopic beads of activated carbon and iron (magnetic targeted carriers). Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids. The placement of a magnet on the body surface overlying a tumor site facilitates this carrier complex to deliver doxorubicin directly to the tumor, thereby prolonging the duration of the therapeutic effects while decreasing systemic toxicity. ( NCI )] (UMLS (NCI) C1134452) Doxorubicin-Magnetic Targeted Carrier Complex;
MTC-DOX; =Organic Chemical; Pharmacologic Substance | - 51. DOX/MeCCNU
- (UMLS (NCI) C0279380) =Therapeutic or Preventive Procedure
|
- 2. DOX-SL
- (UMLS (NCI) C0701182) =Organic Chemical; Pharmacologic Substance ;
| - 52. DOX/MeCCNU/SZC
- (UMLS (NCI) C0279268) =Therapeutic or Preventive Procedure
|
- 3. DOX/5-FU/GM-CSF/MTX
- (UMLS (NCI) C0280205) =Therapeutic or Preventive Procedure
| - 53. DOX/MePRDL
- (UMLS (NCI) C0796442) Doxorubicin/Methylprednisolone =Therapeutic or Preventive Procedure ;
|
- 4. DOX/5-FU/L-PAM
- (UMLS (NCI) C0279389) =Therapeutic or Preventive Procedure
| - 54. DOX/MITO
- (UMLS (NCI) C0279188) =Therapeutic or Preventive Procedure
|
- 5. DOX/5-FU/L-PAM/TMX
- (UMLS (NCI) C0279796) =Therapeutic or Preventive Procedure
| - 55. DOX/MITO/VBL
- (UMLS (NCI) C0052712) =Therapeutic or Preventive Procedure ;
|
- 6. DOX/5-FU/MeCCNU
- (UMLS (NCI) C0280593) =Therapeutic or Preventive Procedure
| - 56. DOX/MITO/VP-16
- (UMLS (NCI) C0280065) =Therapeutic or Preventive Procedure
|
- 7. DOX/5-FU/MITO/MTX
- (UMLS (NCI) C0279534) =Therapeutic or Preventive Procedure
| - 57. DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0278924) =Therapeutic or Preventive Procedure
|
- 8. DOX/5-FU/MITO/SZC
- (UMLS (NCI) C0207828) =Therapeutic or Preventive Procedure
| - 58. DOX/MTX
- (UMLS (NCI) C0281523) =Therapeutic or Preventive Procedure
|
- 9. DOX/5-FU/MITO/TZT
- (UMLS (NCI) C0279447) =Therapeutic or Preventive Procedure
| - 59. DOX/MTX/PRED/VCR
- (UMLS (NCI) C0279197) =Therapeutic or Preventive Procedure
|
- 10. DOX/5-FU/MITO/VCR
- (UMLS (NCI) C0280592) =Therapeutic or Preventive Procedure
| - 60. DOX/MTX/VCR
- (UMLS (NCI) C0280061) =Therapeutic or Preventive Procedure
|
- 11. DOX/5-FU/MTX
- (UMLS (NCI) C0051571) =Therapeutic or Preventive Procedure ;
| - 61. DOX/PCB/PRED/VCR
- (UMLS (NCI) C0058827) =Therapeutic or Preventive Procedure ;
|
- 12. DOX/5-FU/MTX/PRED/TSPA/VBL
- (UMLS (NCI) C0279278) =Therapeutic or Preventive Procedure ;
| - 62. DOX/PCPZ
- (UMLS (NCI) C0280750) =Therapeutic or Preventive Procedure
|
- 13. DOX/5-FU/TMX/TSPA
- (UMLS (NCI) C0280699) =Therapeutic or Preventive Procedure
| - 63. DOX/PEG-ASP/PRED/VCR
- (UMLS (NCI) C0281219) =Therapeutic or Preventive Procedure ;
|
- 14. DOX/5-FU/TSPA
- (UMLS (NCI) C0280681) =Therapeutic or Preventive Procedure
| - 64. DOX/PRDL/VCR
- (UMLS (NCI) C0281484) =Therapeutic or Preventive Procedure
|
- 15. DOX/5-FU/TZT
- (UMLS (NCI) C0279453) =Therapeutic or Preventive Procedure
| - 65. DOX/PRED
- (UMLS (NCI) C0279013) =Therapeutic or Preventive Procedure ;
|
- 16. DOX/5-FU/VBL
- (UMLS (NCI) C0279998) =Therapeutic or Preventive Procedure
| - 66. DOX/PRED/VM-26
- (UMLS (NCI) C0279511) =Therapeutic or Preventive Procedure
|
- 17. DOX/5-FU/VNB
- (UMLS (NCI) C0281298) =Therapeutic or Preventive Procedure
| - 67. DOX/PRED/VP-16
- (UMLS (NCI) C0279891) =Therapeutic or Preventive Procedure
|
- 18. DOX/DPPE
- (UMLS (NCI) C0392975) =Therapeutic or Preventive Procedure ;
| - 68. DOX/progesterone
- (UMLS (NCI) C0392995) =Therapeutic or Preventive Procedure
|
- 19. DOX/DuP-941
- (UMLS (NCI) C0338273) =Therapeutic or Preventive Procedure ;
| - 69. DOX/PSC 833
- (UMLS (NCI) C0392966) =Therapeutic or Preventive Procedure ;
|
- 20. DOX/EDAM
- (UMLS (NCI) C0281407) =Therapeutic or Preventive Procedure ;
| - 70. DOX/QND
- (UMLS (NCI) C0280652) =Therapeutic or Preventive Procedure
|
- 21. DOX/EM
- (UMLS (NCI) C0338295) =Therapeutic or Preventive Procedure
| - 71. DOX/QND/VP-16
- (UMLS (NCI) C0279040) =Therapeutic or Preventive Procedure
|
- 22. DOX/EM/KCZ/VBL
- (UMLS (NCI) C0677757) =Therapeutic or Preventive Procedure
| - 72. DOX/SUR
- (UMLS (NCI) C0280983) =Therapeutic or Preventive Procedure
|
- 23. DOX/ESDL/TSPA/VBL/ZDX
- (UMLS (NCI) C0280898) =Therapeutic or Preventive Procedure
| - 73. DOX/SZC
- (UMLS (NCI) C0281271) =Therapeutic or Preventive Procedure
|
- 24. DOX/Ethiodized Oil
- (UMLS (NCI) C0280636) =Therapeutic or Preventive Procedure
| - 74. DOX/TAX
- (UMLS (NCI) C0280905) =Therapeutic or Preventive Procedure
|
- 25. DOX/FT/MITO
- (UMLS (NCI) C0279365) =Therapeutic or Preventive Procedure
| - 75. DOX/TOPO
- (UMLS (NCI) C0281396) =Therapeutic or Preventive Procedure ;
|
- 26. DOX/FUDR
- (UMLS (NCI) C0278914) =Therapeutic or Preventive Procedure
| - 76. DOX/Trifluoperazine/VBL/VPAM
- (UMLS (NCI) C0281142) =Therapeutic or Preventive Procedure
|
- 27. DOX/FUDR/MITO
- (UMLS (NCI) C0280007) =Therapeutic or Preventive Procedure
| - 77. DOX/TSPA
- (UMLS (NCI) C0280987) =Therapeutic or Preventive Procedure
|
- 28. DOX/FXM/TMX/TSPA/VBL
- (UMLS (NCI) C0279272) =Therapeutic or Preventive Procedure
| - 78. DOX/TSPA/VBL
- (UMLS (NCI) C0279686) =Therapeutic or Preventive Procedure
|
- 29. DOX/FXM/TSPA/VBL
- (UMLS (NCI) C0075860) =Therapeutic or Preventive Procedure
| - 79. DOX/VBL
- (UMLS (NCI) C0280930) =Therapeutic or Preventive Procedure
|
- 30. DOX/G-CSF
- (UMLS (NCI) C0281141) =Therapeutic or Preventive Procedure
| - 80. DOX/VBL/VP-16
- (UMLS (NCI) C0255874) =Therapeutic or Preventive Procedure
|
- 31. DOX/G-CSF/IFF
- (UMLS (NCI) C0281618) =Therapeutic or Preventive Procedure
| - 81. DOX/VCR/VP-16
- (UMLS (NCI) C0078136) =Therapeutic or Preventive Procedure
|
- 32. DOX/G-CSF/MP/PRED/VCR
- (UMLS (NCI) C0281131) =Therapeutic or Preventive Procedure
| - 82. DOX/VCR/VX-710
- (UMLS (NCI) C0796603) Doxorubicin/Vincristine/VX-710 =Therapeutic or Preventive Procedure
|
- 33. DOX/G-CSF/PRED/VCR
- (UMLS (NCI) C0281132) =Therapeutic or Preventive Procedure
| - 83. DOX/VNB
- (UMLS (NCI) C0281256) =Therapeutic or Preventive Procedure ;
|
- 34. DOX/G-CSF/TAX
- (UMLS (NCI) C0280906) =Therapeutic or Preventive Procedure
| - 84. DOX/VPAM
- (UMLS (NCI) C0281009) =Therapeutic or Preventive Procedure
|
- 35. DOX/G-CSF/TSPA
- (UMLS (NCI) C0280986) =Therapeutic or Preventive Procedure
| - 85. DOX/VX-710
- (UMLS (NCI) C0338355) =Therapeutic or Preventive Procedure ;
|
- 36. DOX/GM-CSF
- (UMLS (NCI) C0280753) =Therapeutic or Preventive Procedure
| - 86. Doxacurium Chloride
- (UMLS (NCI) C0114872) =Organic Chemical; Pharmacologic Substance ;
=doxacurium; =DOXACURIUM CHLORIDE 1 MG/ML |
- 37. DOX/GM-CSF/IFF
- (UMLS (NCI) C0279011) =Therapeutic or Preventive Procedure ;
| - 87. DOXAPRAM
- [A respiratory stimulant with analeptic activity. Doxapram, independent of oxygen levels, directly stimulates the peripheral carotid chemoreceptors, possibly by inhibiting the potassium channels of type I cells within the carotid body, thereby stimulating catecholamines release. This results in the prevention or reversal of both narcotic- and CNS depressant-induced respiratory depression. ( NCI )] (UMLS (NCI) C0013084) =Organic Chemical; Pharmacologic Substance ;
=Pyrrolidinones; [RE900] RESPIRATORY AGENTS, OTHER =1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate |
- 38. DOX/HU
- (UMLS (NCI) C0281440) =Therapeutic or Preventive Procedure
| - 88. DOXAZOSIN
- [A quinazoline with antihypertensive and antineoplastic properties. Doxazosin is an alpha-adrenergic antagonist that selectively inhibits alpha-1 adrenergic receptors. Blockages of the alpha-1 adrenergic action on the vascular smooth muscles lead to a decrease in vascular resistance and antihypertensive activity. This agent also shows high affinity to alpha-1c adrenoceptor, the predominant functional type in the prostate, which may partially attribute to its effect in treatment of benign prostatic hyperplasia. Furthermore, doxazosin induces apoptosis in prostate cancer cells mediated through inhibition of protein kinase B (PKB)/Akt-signaling death receptor regulatory pathway. ( NCI )] (UMLS (NCI) C0114873) =Organic Chemical; Pharmacologic Substance ;
=1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; [CV150] ALPHA-BLOCKERS/RELATED =DOXAZOSIN MESYLATE |
- 39. DOX/ICI D1694
- (UMLS (NCI) C0677753) =Therapeutic or Preventive Procedure ;
| - 89. Doxefazepam
- (UMLS (NCI) C0114875) =Organic Chemical; Pharmacologic Substance ;
|
- 40. DOX/IFF
- (UMLS (NCI) C0278906) =Therapeutic or Preventive Procedure
| - 90. doxepin
- [A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. ( MSH )] (UMLS (CSP) C0013085) =Organic Chemical; Pharmacologic Substance ;
=[CN601] TRICYCLIC ANTIDEPRESSANTS; Dibenzoxepins; [DE900] DERMATOLOGICALS, TOPICAL OTHER; =DOXEPIN HYDROCHLORIDE |
- 41. DOX/IFF/MTP-PE Liposome/MTX
- (UMLS (NCI) C0281526) =Therapeutic or Preventive Procedure
| - 91. doxil
- [ ] (UMLS (CSP) C0279284) =Organic Chemical; Pharmacologic Substance
|
- 42. DOX/IFF/MTX
- (UMLS (NCI) C0279209) =Therapeutic or Preventive Procedure
| - 92. Doxorubicin HCl Liposome/Etoposide
- (UMLS (NCI) C0678096) =Therapeutic or Preventive Procedure
|
- 43. DOX/IFF/PRED/VCR
- (UMLS (NCI) C0279185) =Therapeutic or Preventive Procedure
| - 93. Doxorubicin Hcl Liposome/Gemcitabine
- (UMLS (NCI) C0879589) =Therapeutic or Preventive Procedure
|
- 44. DOX/IFF/VCR
- (UMLS (NCI) C0279210) =Therapeutic or Preventive Procedure
| - 94. Doxorubicin Hcl Liposome/Gemcitabine/Vinorelbine
- (UMLS (NCI) C0879571) =Therapeutic or Preventive Procedure
|
- 45. DOX/IFF/VP-16
- (UMLS (NCI) C0677752) =Therapeutic or Preventive Procedure ;
| - 95. Doxorubicin Hcl Liposome/Ifosfamide
- (UMLS (NCI) C1134566) =Therapeutic or Preventive Procedure
|
- 46. DOX/IFN-A
- (UMLS (NCI) C0338120) =Therapeutic or Preventive Procedure ;
| - 96. Doxorubicin Hcl Liposome/Interleukin-12
- (UMLS (NCI) C0935798) =Therapeutic or Preventive Procedure
|
- 47. DOX/IL-2
- (UMLS (NCI) C0278683) =Therapeutic or Preventive Procedure
| - 97. Doxorubicin Hcl Liposome/Methotrexate/Prednisone/Vincristine
- (UMLS (NCI) C0879375) =Therapeutic or Preventive Procedure
|
- 48. DOX/KCZ
- (UMLS (NCI) C0281712) =Therapeutic or Preventive Procedure
| - 98. Doxorubicin HCl Liposome/Paclitaxel
- (UMLS (NCI) C0678066) =Therapeutic or Preventive Procedure ;
|
- 49. DOX/L-PAM/MePRDL
- (UMLS (NCI) C0281313) =Therapeutic or Preventive Procedure ;
| - 99. Doxorubicin HCl Liposome/PSC 833
- (UMLS (NCI) C0677968) =Therapeutic or Preventive Procedure
|
- 50. DOX/L-PAM/VM-26
- (UMLS (NCI) C0279939) =Therapeutic or Preventive Procedure
| - 100. Doxorubicin HCl Liposome/Topotecan
- (UMLS (NCI) C0678077) =Therapeutic or Preventive Procedure ;
|